Identification of a key pathway required for the sterile inflammatory response triggered by dying cells - PubMed (original) (raw)
doi: 10.1038/nm1603. Epub 2007 Jun 17.
Affiliations
- PMID: 17572686
- DOI: 10.1038/nm1603
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells
Chun-Jen Chen et al. Nat Med. 2007 Jul.
Abstract
Dying cells stimulate inflammation, and this response is thought to contribute to the pathogenesis of many diseases. Very little has been known, however, about how cell death triggers inflammation. We found here that the acute neutrophilic inflammatory response to cell injury requires the signaling protein myeloid differentiation primary response gene 88 (Myd88). Analysis of the contribution of Myd88-dependent receptors to this response revealed only a minor reduction in mice doubly deficient in Toll-like receptor 2 (Tlr2) and Tlr4 and normal responses in mice lacking Tlr1, Tlr3, Tlr6, Tlr7, Tlr9, Tlr11 or the interleukin-18 receptor (IL-18R). However, mice lacking IL-1R showed a markedly reduced neutrophilic inflammatory response to dead cells and tissue injury in vivo as well as greatly decreased collateral damage from inflammation. This inflammatory response required IL-1alpha, and IL-1R function was required on non-bone-marrow-derived cells. Notably, the acute monocyte response to cell death, which is thought to be important for tissue repair, was much less dependent on the IL-1R-Myd88 pathway. Also, this pathway was not required for the neutrophil response to a microbial stimulus. These findings suggest that inhibiting the IL-1R-Myd88 pathway in vivo could block the damage from acute inflammation that occurs in response to sterile cell death, and do so in a way that might not compromise tissue repair or host defense against pathogens.
Comment in
- IL-1alpha responds to necrotic cell death.
Elkon KB. Elkon KB. Nat Med. 2007 Jul;13(7):778-80. doi: 10.1038/nm0707-778. Nat Med. 2007. PMID: 17618263 No abstract available.
Similar articles
- The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury.
Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, Chen Q, Li C, Li J, Li Y. Cao Z, et al. Cardiovasc Res. 2009 Dec 1;84(3):442-51. doi: 10.1093/cvr/cvp234. Epub 2009 Jul 8. Cardiovasc Res. 2009. PMID: 19586942 - MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus.
Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE, Thirumala A, Cheung AL, Cheng G, Modlin RL. Miller LS, et al. Immunity. 2006 Jan;24(1):79-91. doi: 10.1016/j.immuni.2005.11.011. Immunity. 2006. PMID: 16413925 - Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection.
Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S, Henriques-Normark B. Albiger B, et al. Cell Microbiol. 2007 Mar;9(3):633-44. doi: 10.1111/j.1462-5822.2006.00814.x. Epub 2006 Sep 27. Cell Microbiol. 2007. PMID: 17004992 - Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S, Miyake K. Saitoh S, et al. Immunol Rev. 2009 Jan;227(1):32-43. doi: 10.1111/j.1600-065X.2008.00729.x. Immunol Rev. 2009. PMID: 19120473 Review. - Molecular determinants of sterile inflammation.
Kono H, Onda A, Yanagida T. Kono H, et al. Curr Opin Immunol. 2014 Feb;26:147-56. doi: 10.1016/j.coi.2013.12.004. Epub 2014 Jan 7. Curr Opin Immunol. 2014. PMID: 24556412 Review.
Cited by
- IL-1α signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge.
Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM, Watschke CP, Hilmer KM, Thammahong A, Barker BM, Rivera A, Cramer RA, Obar JJ. Caffrey AK, et al. PLoS Pathog. 2015 Jan 28;11(1):e1004625. doi: 10.1371/journal.ppat.1004625. eCollection 2015 Jan. PLoS Pathog. 2015. PMID: 25629406 Free PMC article. - Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma.
Khalili JS, Liu S, Rodríguez-Cruz TG, Whittington M, Wardell S, Liu C, Zhang M, Cooper ZA, Frederick DT, Li Y, Zhang M, Joseph RW, Bernatchez C, Ekmekcioglu S, Grimm E, Radvanyi LG, Davis RE, Davies MA, Wargo JA, Hwu P, Lizée G. Khalili JS, et al. Clin Cancer Res. 2012 Oct 1;18(19):5329-40. doi: 10.1158/1078-0432.CCR-12-1632. Epub 2012 Jul 31. Clin Cancer Res. 2012. PMID: 22850568 Free PMC article. - Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
Dinarello CA, Simon A, van der Meer JW. Dinarello CA, et al. Nat Rev Drug Discov. 2012 Aug;11(8):633-52. doi: 10.1038/nrd3800. Nat Rev Drug Discov. 2012. PMID: 22850787 Free PMC article. Review. - Danger signals activating the immune response after trauma.
Hirsiger S, Simmen HP, Werner CM, Wanner GA, Rittirsch D. Hirsiger S, et al. Mediators Inflamm. 2012;2012:315941. doi: 10.1155/2012/315941. Epub 2012 Jun 19. Mediators Inflamm. 2012. PMID: 22778496 Free PMC article. Review. - Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury.
Scheiermann P, Bachmann M, Härdle L, Pleli T, Piiper A, Zwissler B, Pfeilschifter J, Mühl H. Scheiermann P, et al. Sci Rep. 2015 Feb 17;5:8521. doi: 10.1038/srep08521. Sci Rep. 2015. PMID: 25687687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases